Ingredient intelligence

Acetyl hexapeptide-8

Peptide · Acetyl Hexapeptide-8 · C34H60N14O12S

Acetyl hexapeptide-8 is a synthetic peptide modelled on a SNAP-25 sequence and studied for neuromuscular-signalling endpoints in vitro.

Molecular identity

Two-dimensional chemical structure of Acetyl hexapeptide-8
Formula
C34H60N14O12S
Molecular weight
888.99 g/mol
PubChem CID
9862105
ChEBI
Data unavailable
Open PubChem record →

Biological targets

  • Synaptosomal-associated protein 25 (SNAP25)

    low confidence

    modulates · structural protein

    Mechanism described in cell-free and cell models; cutaneous relevance unresolved.

    UniProt P60880

Molecules & genes

Molecules

  • Acetyl hexapeptide-8C34H60N14O12S · 888.99 g/mol

Genes / proteins

How could this ingredient interact with biology?

Biological network

Ingredient → molecule → target → gene/protein → pathway → process → studied outcome. Relationship strength is drawn from the curated confidence tier; nothing is added to make the chain look complete.

100%
Acetyl hexapeptide-8Acetyl hexapeptide-8

drag to pan · hover to isolate a path · click a node for detail

IngredientMoleculeTargetGenePathwayProcessOutcome

5 lower-confidence relationships are hidden at this filter level. Use “Show more biology” to include them.

Text alternative for this network
  • Acetyl hexapeptide-8 is molecule Acetyl hexapeptide-8high confidence

Biological pathways

Neurotransmitter release cycle

low confidence

SNARE-complex assembly step targeted in vitro.

Reactome R-HSA-112310

Evidence engine

Insufficient

Not enough curated evidence to characterise this ingredient.

Skinceptor Evidence Index

11

experimental · of 100

This index is a research-navigation aid describing how much evidence exists and how it was produced. It is not a medical safety score, an efficacy guarantee, or a clinical recommendation.

Study composition

  • In-vitro1
Total studies
1
Human studies
0
Largest sample
Data unavailable
Range
2002–2002

Index breakdown

  • Study design quality25% × 28%

    Mean design weight across curated studies (meta-analysis 1.0, RCT 0.9, other human 0.7, review 0.45, animal 0.35, in-vitro 0.25).

  • Human evidence share0% × 22%

    Proportion of curated evidence measured in people rather than cells or animals.

  • Evidence volume32% × 14%

    Log-scaled count of curated studies, so volume alone cannot dominate the score.

  • Largest sample size0% × 12%

    Log-scaled largest reported sample size across curated human studies.

  • Replication0% × 12%

    Independent human studies, capped at three; one study is never treated as replicated.

  • Recency0% × 7%

    Linear decay over a twenty-year window from the most recent curated publication.

  • Source traceability0% × 5%

    Share of curated studies with a verified PMID or DOI in this dataset.

How is this determined? →

Insufficient comparable evidence for quantitative synthesis.

Research timeline

How the evidence accumulated

  1. 2002

    Acetyl hexapeptide-8 and SNARE complex assembly in vitro

    In-vitrosample size unavailable · International Journal of Cosmetic Science

Ingredient fingerprint

7 nodes · 6 relationships · seed "acetyl-hexapeptide-8"

The fingerprint is a deterministic visual signature: ridge amplitude comes from the number of entities in each tier, node placement from identifier hashes, and opacity from confidence. Two ingredients can never produce the same figure unless their networks are identical.

Open in Biology as Art →

Research

1 curated study

In-vitroInternational Journal of Cosmetic Science · 2002

Acetyl hexapeptide-8 and SNARE complex assembly in vitro

Reported interference with SNAP-25 dependent complex formation in a cell-free system.

LimitationsCell-free system; cutaneous penetration to neuromuscular junctions not demonstrated.

Community evidence

Submitted by readers

Submit a study

Reader submissions appear here only after review. They are not part of the curated dataset and do not affect the Skinceptor Evidence Index.

No approved community submissions yet.

Sources